- Home
- CPT vs RVTY Comparison
CPT vs RVTY Comparison
Compare CPT & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPT
- RVTY
- Stock Information
- Founded
- CPT 1993
- RVTY 1937
- Country
- CPT United States
- RVTY United States
- Employees
- CPT N/A
- RVTY N/A
- Industry
- CPT Real Estate Investment Trusts
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- CPT Real Estate
- RVTY Industrials
- Exchange
- CPT Nasdaq
- RVTY Nasdaq
- Market Cap
- CPT 10.9B
- RVTY 9.9B
- IPO Year
- CPT 1993
- RVTY N/A
- Fundamental
- Price
- CPT $102.36
- RVTY $93.15
- Analyst Decision
- CPT Buy
- RVTY Buy
- Analyst Count
- CPT 19
- RVTY 13
- Target Price
- CPT $121.14
- RVTY $112.92
- AVG Volume (30 Days)
- CPT 1.5M
- RVTY 1.3M
- Earning Date
- CPT 11-06-2025
- RVTY 10-27-2025
- Dividend Yield
- CPT 4.12%
- RVTY 0.31%
- EPS Growth
- CPT N/A
- RVTY N/A
- EPS
- CPT 2.47
- RVTY 1.99
- Revenue
- CPT $1,578,428,000.00
- RVTY $2,813,367,000.00
- Revenue This Year
- CPT $2.74
- RVTY $5.37
- Revenue Next Year
- CPT $2.57
- RVTY $3.07
- P/E Ratio
- CPT $41.27
- RVTY $46.71
- Revenue Growth
- CPT 1.41
- RVTY 3.37
- 52 Week Low
- CPT $97.17
- RVTY $81.36
- 52 Week High
- CPT $127.65
- RVTY $128.29
- Technical
- Relative Strength Index (RSI)
- CPT 49.36
- RVTY 51.32
- Support Level
- CPT $101.26
- RVTY $88.48
- Resistance Level
- CPT $103.78
- RVTY $95.79
- Average True Range (ATR)
- CPT 1.87
- RVTY 2.82
- MACD
- CPT 0.30
- RVTY -0.23
- Stochastic Oscillator
- CPT 76.15
- RVTY 63.72
About CPT Camden Property Trust
Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 177 multifamily properties comprised of nearly 59,996 apartment homes across the United States.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.